Integrated Applications Promotion

Integrity Applications, Inc. Announces Filing of Form S-3 Shelf Registration Statement

Retrieved on: 
Monday, September 20, 2021
News, OTCQB, Ministry, Risk, Annual report, Ear, Form S-3, Sale, Private Securities Litigation Reform Act, FDA, U.S. Securities and Exchange Commission, Patient, Registration statement, Securities and Exchange Commission (Philippines), Glycated hemoglobin, Integrated Applications Promotion, DE, Form, Company, Pain, Securities Act of 1933, Register, Integrity, Prediabetes, Prospectus, CE marking, Type 2 diabetes, Time, SEC, GLOBE, Ministry of Food and Drug Safety, Security (finance)

The filing of this Registration Statement provides the potential opportunity and flexibility to access the capital markets in a timely and cost-effective manner.

Key Points: 
  • The filing of this Registration Statement provides the potential opportunity and flexibility to access the capital markets in a timely and cost-effective manner.
  • There are no specific plans to issue Securities under the registration statement at this time, and no underwriter has been contemplated or engaged for any offering.
  • The shelf registration statement relating to these securities has been filed with the SEC but has not yet become effective.
  • These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.

Global Point-of-Care Glucose Testing Market Analysis 2021-2028: Accu-Check Aviva Meter, Onetouch Verio Flex, i-STAT, Freestyle Lite, Bayer CONTOUR, True Metrix, Accu-Check Inform II, StatStrip - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 17, 2021
Diabetes, Health, Medical Supplies, Medical Devices, Chek, Industry, CAGR, Bayer, Gold, Skin, Diagnosis, Point-of-care testing, Carbohydrate metabolism, Diabetes, Platinum, Integrated Applications Promotion, Asia-Pacific, POCT, Asia, POC, Silver, COVID-19, Patient, MEA, LifeScan, LATAM, Medical device, Medical imaging, Fine chemical

As compared to the conventional laboratory testing performed central lab settings, glucose POCT aids in performing effective diagnosis at the patient's bedside.

Key Points: 
  • As compared to the conventional laboratory testing performed central lab settings, glucose POCT aids in performing effective diagnosis at the patient's bedside.
  • Easy and convenient operation of POCT has largely favored the growing usage of glucose meters across medical settings.
  • Various companies are investing in the development of needle-less blood glucose monitoring devices to offer painless management of diabetes in patients.
  • 3.3 Point-of-Care (POC) Glucose Testing Market: Covid-19 Impact Analysis
    Chapter 4 Point-of-Care (POC) Glucose Testing: Product Estimates & Trend Analysis
    4.4 Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following

Integrity Applications, Inc. Implements Reverse Stock Split To Meet NASDAQ Initial Listing Requirements

Retrieved on: 
Thursday, August 12, 2021
Transfer, CE marking, NASDAQ, U.S. Securities and Exchange Commission, Annual general meeting, News, Integrated Applications Promotion, Book, Company, Prediabetes, Ministry of Food and Drug Safety, Private Securities Litigation Reform Act, OTCQB, Ministry, GLOBE, Bangladesh Securities and Exchange Commission, DE, SEC, Shareholder, Integrity, FDA, Annual report, Board, Patient, Special-purpose acquisition company, Pain, Risk, Board of directors, Type 2 diabetes, Ear, Glycated hemoglobin, Medical device, Security (finance)

On July 28, 2021, the Company's Board of Directors approved the implementation of the reverse stock split and determined the appropriate reverse stock split to be a ratio of 1-for-13.

Key Points: 
  • On July 28, 2021, the Company's Board of Directors approved the implementation of the reverse stock split and determined the appropriate reverse stock split to be a ratio of 1-for-13.
  • The reverse stock split is being implemented by the Company in connection with its application to uplist its common stock to the NASDAQ Capital Market (NASDAQ).
  • The reverse stock split is an action intended to fulfill the stock price requirements for official listing on NASDAQ, which requires that the Company's common stock price be at$4.00or higher at the time of listing.
  • The reverse stock split will reduce the number of shares of issued and outstanding common stock from 200,781,597 pre-split to approximately 15,444,738 post-split.